HEALTH● LOWOct 2 · Oct 2, 2026, 6:21 PM
Experimental Combo Boosts Weight Loss in T2D
Human Progress · global
“A next-generation weight-loss drug from Eli Lilly red down pointing triangle, when combined with Zepbound, helped people lose substantially more weight than Zepbound alone, according to a new study. The experimental injection, eloralintide, which mimics a hormone called amylin that helps signal fullness after eating, was studied in combination with a Zepbound shot in patients […] The post Experimental Combo Boosts Weight Loss in T2D appeared first on Human Progress.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH8m agoFG releases ₦40.7 billion for primary healthcare, expands coverage to 13,000 facilitiesPremium TimesHEALTH15m agoAmericans with disabilities worried over plan to slash national health surveyThe Independent WorldHEALTH26m agoWATCH: Measles, GLP-1s and anti-aging: How to protect your healthABC NewsHEALTH36m agoKenya Announces Second Ebola Case, Says ‘No Evidence’ Of Wider SpreadChannels TV